Invesaro

Stocks FSI Financial statements

Financial statements

FLEXIBLE SOLUTIONS INTERNATIONAL INC financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data FLEXIBLE SOLUTIONS INTERNATIONAL INC files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue16.215.517.827.431.434.445.838.338.238.5
Cost of revenue9.269.5112.218.821.6233227.92526
Gross profit6.995.995.648.629.7711.413.910.413.212.5
Research and development0.10.10.140.120.080.120.10.160.330.62
Selling, general and administrative2.853.64
Selling and marketing0.020.020.070.160.20.170.180.190.22
Operating expenses3.94.474.336.715.655.916.826.947.727.94
Operating income3.091.511.311.914.125.487.053.55.524.6
Interest expense0.040.040.090.430.260.20.290.5
Interest income000.040.080.050.080.130.110.20.15
Other non-operating income0.12-0.56-1.33
Pre-tax income3.083.423.052.315.196.657.863.624.953.27
Income tax0.980.680.530.021.612.360.15-0.130.850.9
Net income to minority interests-0.070.380.610.850.690.981.061.58
Net income1.791.752.491.912.983.457.022.783.040.79
EBITDA3.611.781.652.534.976.458.335.197.476.57
EPS, basic0.160.150.210.160.240.280.570.220.240.06
EPS, diluted0.150.150.210.160.240.280.560.220.240.06
Shares, basic (weighted)11.511.511.611.912.212.312.412.412.512.6
Shares, diluted (weighted)11.611.711.812.112.312.512.512.512.713.6

Balance sheet

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash and equivalents2.476.917.863.633.475.716.125.027.636.63
Short-term investments11.030.72.692.4
Receivables3.012.114.424.475.897.139.459.8411.712.6
Inventory3.794.698.739.188.379.514.411.110.910.5
Other current assets0.230.260.20.220.30.440.311.541.961.33
Total current assets9.491421.217.51923.83130.234.632.9
Property, plant and equipment3.391.942.564.015.144.939.7113.217.116.1
Lease right-of-use assets0.790.480.220.170.123.79
Goodwill2.532.532.532.532.532.532.532.53
Intangible assets0.10.083.132.952.782.62.442.282.121.96
Long-term investments0.122.05
Total assets15.217.831.232.435.139.651.655.56061.8
Accounts payable0.90.940.860.640.561.280.871.982.052.22
Accrued liabilities0.190.181.230.460.960.280.40.5
Deferred revenue0.10.210.130.210.310.350.390.150.080.12
Short-term debt0.550.20.771.20.850.790.720.062.140.4
Total current liabilities2.342.76.16.797.899.8210.310.111.910.8
Long-term debt0.350.153.583.1831.575.446.836.624.04
Lease liabilities0.380.20.140.110.063.92
Total liabilities2.692.8511.711.911.311.816.317.218.619
Total debt0.550.354.354.383.852.376.158.118.764.44
Paid-in capital14.815.115.316.416.61717.517.918.819.9
Retained earnings-1.30.452.942.465.438.8815.918.119.819.3
Other comprehensive income-1.09-0.66-1.22-0.99-0.87-0.78-0.81-0.8-0.61-0.35
Shareholders' equity12.514.917.117.921.225.132.635.23838.9
Minority interests2.462.552.562.62.613.073.333.92
Total equity12.514.919.520.523.827.735.238.341.442.8
Total liabilities and equity15.217.831.232.435.139.651.655.56061.8
Shares outstanding11.511.611.712.212.312.412.412.412.512.7

Cash flow statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Net income1.791.752.422.33.584.297.713.764.12.37
Depreciation and amortization0.520.270.340.620.850.971.281.691.961.97
Stock-based compensation0.070.120.110.250.160.210.40.40.670.56
Deferred income tax0.30.990.1-0.60.410.36-0.07-0.250.150.16
Change in receivables-1.20.91-1.05-0.32-1.42-1.25-2.34-0.39-1.85-0.93
Change in inventory-0.51-0.89-2.19-0.481.28-1.28-4.123.280.240.35
Change in payables0.09-0.41-0.35-0.310.550.1-0.71.110.060.6
Cash from operations1.781.04-2.232.375.714.541.486.125.573.78
Capital expenditures-0.11-0.43-0.18-1.83-1.08-0.78-1.98-4.99-4.96-4.37
Acquisitions-4.110.01-0.5
Purchases of investments-1-3.15-0.5-0.47
Cash from investing-0.222.97-2.56-2.67-3.22-0.66-2.22-4.85-2.160.89
Debt issued1.13.413.232.692.16
Debt repaid-0.2-1.07-4.4-0.94-2.29-0.73-1.52-4.32
Stock issued0.030.160.10.360.040.140.140.010.180.55
Share buybacks-1.58
Dividends paid-2.4-0.63-1.26-1.27
Cash from financing-1.69-0.056.13-3.09-2.7-1.710.85-0.38-0.98-5.94
Exchange rate effect0.110.47-0.46
Net change in cash-0.034.440.95-3.22-0.162.260.080.892.61-1.01
Free cash flow1.660.62-2.410.544.623.75-0.51.130.6-0.59
Interest paid0.040.040.090.430.260.180.290.50.610.61
Income taxes paid0.450.830.290.210.460.160.120.050.82

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $5.80 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Gross margin19.1%Gross profit / revenue.
Operating margin-2.6%Operating income / revenue.
EBITDA margin3.0%EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin-6.5%Pre-tax income / revenue.
Net margin-8.8%Net income / revenue.
FCF margin-9.8%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin7.1%Cash from operations / revenue.
Return on equity (ROE)-8.4%Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)-5.3%Net income / average total assets.
Return on invested capital (ROIC)-2.2%Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue1.6%Research and development expense / revenue.
Stock-based pay / revenue1.6%Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue16.9%Capital expenditures / revenue.
D&A / revenue5.6%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y0.7%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y-5.6%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y4.2%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y-5.3%Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y-3.3%Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y5.1%Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y-16.6%Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y-13.3%Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y2.2%Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y-12.1%EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y-7.6%Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y5.7%Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y-74.1%Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y-51.8%Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y-23.4%Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y-75.0%EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y-52.5%Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y-24.2%Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y-32.1%Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y36.8%Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y-7.9%Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y-198.0%Free cash flow vs the same period a year earlier. Only from a positive base.
Book value growth, 1y2.3%Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y6.0%Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y12.9%Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y3.1%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y6.2%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y12.0%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y7.2%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y2.9%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y2.0%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio2.82xCurrent assets / current liabilities.
Quick ratio1.18x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio0.74x(Cash + short-term investments) / current liabilities.
Debt / equity0.11xTotal debt / shareholders' equity. Not shown when equity is negative.
Debt / assets7.2%Total debt / total assets.
Liabilities / assets30.7%Total liabilities / total assets.
Net debt-$3.4MTotal debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA-3.22xNet debt / EBITDA (twelve months), when EBITDA is positive.
Working capital$18.7MCurrent assets - current liabilities.
Goodwill and intangibles / assets10.6%(Goodwill + intangible assets) / total assets.
Tangible book value$30.8MShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover0.60xRevenue / average total assets.
Fixed asset turnover1.97xRevenue / average property, plant and equipment.
Inventory turnover1.91xCost of revenue / average inventory.
Days inventory191 days365 x average inventory / cost of revenue.
Receivables turnover8.01xRevenue / average receivables.
Days sales outstanding46 days365 x average receivables / revenue.
Days payables39 days365 x average accounts payable / cost of revenue.
Cash conversion cycle198 daysDays inventory + days sales outstanding - days payables.
Capex / operating cash flow237.2%Capital expenditures / cash from operations, when that is positive.

Per share

MetricValueHow it is calculated
EPS, diluted-$0.24Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share$2.79Revenue / diluted weighted shares.
FCF per share-$0.27Free cash flow / diluted weighted shares.
Operating cash flow per share$0.20Cash from operations / diluted weighted shares.
Book value per share$2.90Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share$2.41Tangible book value / shares outstanding.
Cash per share$0.60(Cash + short-term investments) / shares outstanding.

Valuation

MetricValueHow it is calculated
Market cap$74.1MShare price x shares outstanding.
Enterprise value$70.7MMarket cap + total debt - cash - short-term investments.
P/S2.08xMarket cap / revenue.
P/B2.00xMarket cap / shareholders' equity. Only when equity is positive.
Price / tangible book2.41xMarket cap / tangible book value, when positive.
P/OCF29.2xMarket cap / cash from operations, when positive.
EV/Sales1.99xEnterprise value / revenue.
EV/EBITDA66.4xEnterprise value / EBITDA, when both are positive.
FCF yield-4.7%Free cash flow / market cap.
Earnings yield-4.2%Net income / market cap (the inverse of P/E).
What was FLEXIBLE SOLUTIONS INTERNATIONAL INC's revenue in fiscal 2025?

FLEXIBLE SOLUTIONS INTERNATIONAL INC reported revenue of $38.5M for fiscal 2025, 0.7% higher than the year before.

Was FLEXIBLE SOLUTIONS INTERNATIONAL INC profitable in fiscal 2025?

Yes. Net income was $786.9K, a net margin of 2%.

How much free cash flow did FLEXIBLE SOLUTIONS INTERNATIONAL INC generate in fiscal 2025?

Cash from operations of $3.8M minus capital expenditures of $4.4M left free cash flow of -$591.7K.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to FLEXIBLE SOLUTIONS INTERNATIONAL INC